Applied dna announces availability and first customer shipment of new linea(tm) ivt evaluation kit

Stony brook, ny / accesswire / august 29, 2023 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced the general availability of linea™ ivt platform evaluation kits (the "kit") and the first shipment of a kit to an existing linea™ ivt template customer. the newly launched kit, comprised of linea™ ivt template, a buffer system, and linea™ rna polymerase (rnap), supports the conversion of current template evaluation customers to linea ivt.
APDN Ratings Summary
APDN Quant Ranking